Document is current
Any future updates will be listed below
-
Authors
Rudman, Yaron https://orcid.org/0000-0003-3220-6321
Michaelis, Michal
Shimon, Ilan https://orcid.org/0000-0002-9188-3894
Dotan, Idit https://orcid.org/0000-0003-0551-4759
Shochat, Tzippy https://orcid.org/0000-0002-7576-8327
Kushnir, Shiri https://orcid.org/0000-0003-2359-5249
Fleseriu, Maria https://orcid.org/0000-0001-9284-6289
Akirov, Amit https://orcid.org/0000-0002-9376-344X
- License Information
-
More Information
Article History
Accepted: 5 November 2024
First Online: 27 December 2024
Declarations
:
: Michal Michaelis, Yaron Rudman, Idit Dotan, Tzipora Shochat, and Shiri Kushnir do not have any financial or personal relationships with other people or organizations to disclose. Ilan Shimon has been an investigator for Xeris Biopharma and has received occasional scientific fee for scientific consulting and advisory boards from Medison, CTS pharma, and Neopharm. Maria Fleseriu has been a PI with research funding to university from Crinetics, and Sparrow and has received occasional scientific fee for scientific consulting and advisory boards from Crinetics, Recordati, Sparrow and Xeris. Amit Akirov has received occasional scientific fee for scientific consulting and advisory boards from Medison, CTS pharma, and Neopharm. All authors declare no competing interests.
